PRFX Stock Summary and Trading Ideas (Painreform Ltd. - | NASDAQ:PRFX)

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Painreform Ltd. - trades on the NASDAQ stock market under the symbol PRFX.

As of January 14, 2026, PRFX stock price climbed to $0.83 with 104,408 million shares trading.

PRFX has a beta of 1.23, meaning it tends to be more sensitive to market movements. PRFX has a correlation of 0.10 to the broad based SPY ETF.

PRFX has a market cap of $3.24 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, PRFX traded as high as $633.84 and as low as $.61.

PRFX has underperformed the market in the last year with a return of -70.9%, while the SPY ETF gained +20.0%. In the last 3 month period, PRFX fell short of the market, returning -31.7%, while SPY returned +4.4%. However, in the most recent 2 weeks PRFX has outperformed the stock market by returning +22.6%, while SPY returned +0.5%.

PRFX support price is $.75 and resistance is $.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRFX shares will trade within this expected range on the day.